A systematic assessment of preclinical multilaboratory studies and a comparison to single laboratory studies

by Victoria T Hunniford, Agnes Grudniewicz, Dean A Fergusson, Joshua Montroy, Emma Grigor, Casey Lansdell, Manoj M Lalu, On behalf of The Canadian Critical Care Translational Biology Group
Published 2023-03-01

Innate immunity activation in the early brain injury period following subarachnoid hemorrhage

by Typhaine Gris, Patrick Laplante, Paméla Thebault, Romain Cayrol, Ahmed Najjar, Benjamin Joannette-Pilon, Frédéric Brillant-Marquis, Elsa Magro, Shane W. English, Réjean Lapointe, Michel Bojanowski, Charles L. Francoeur, Jean-François Cailhier, on behalf of the Canadian Critical Care Translational Biology Group
Published 2019-12-01

Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial

by Manoj M Lalu, Katrina J Sullivan, Shirley HJ Mei, David Moher, Alexander Straus, Dean A Fergusson, Duncan J Stewart, Mazen Jazi, Malcolm MacLeod, Brent Winston, John Marshall, Brian Hutton, Keith R Walley, Lauralyn McIntyre, on behalf of the Canadian Critical Care Translational Biology Group
Published 2016-11-01

Sex-based analysis of treatment responses in animal models of sepsis: a preclinical systematic review protocol

by MengQi Zhang, Dean A. Fergusson, Rahul Sharma, Ciel Khoo, Asher A. Mendelson, Braedon McDonald, Kimberly F. Macala, Neha Sharma, Sean E. Gill, Kirsten M. Fiest, Christian Lehmann, Risa Shorr, Forough Jahandideh, Stephane L. Bourque, Patricia C. Liaw, Alison Fox-Robichaud, Manoj M. Lalu, on behalf of the Canadian Critical Care Translational Biology Group, the Sepsis Canada National Preclinical Sepsis Platform
Published 2023-03-01

Immunothrombosis Biomarkers for Distinguishing Coronavirus Disease 2019 Patients From Noncoronavirus Disease Septic Patients With Pneumonia and for Predicting ICU Mortality

by Erblin Cani, BSc, Dhruva J. Dwivedi, PhD, Kao-Lee Liaw, PhD, Douglas D. Fraser, MD, PhD, FRCPC, Calvin H. Yeh, MD, PhD, Claudio Martin, MSc, MD, FRCPC, Marat Slessarev, MD, PhD, FRCPC, Samantha E. Cerroni, BSc, Alison A. Fox-Robichaud, MSc, MD, FRCPC, Jeffrey I. Weitz, MD, FRCPS, Paul Y. Kim, PhD, Patricia C. Liaw, PhD, on behalf of the Canadian Critical Care Translational Biology Group (CCCTBG) and the COVID-BEACONS investigators
Published 2021-12-01

Diagnostic Potential of Coagulation-Related Biomarkers for Sepsis in the Emergency Department: Protocol for a Pilot Observational Cohort Study

by Jaskirat Arora, MBBS, Jennifer A. Klowak, MD, MSc, FRCPC, Sameer Parpia, MSc, PhD, Marcelo Zapata-Canivilo, MD, Walaa Faidi, MSc, Christopher Skappak, MD, PhD, Rachael Gregoris, BHSc, Colin A. Kretz, BSc, PhD, Dhruva J. Dwivedi, BSc, MSc, PhD, Kerstin de Wit, BSc, MSc, MB ChB, MD, FRCPC, FRCEM, MRCP, Michelle Welsford, BSc, MD, FACEP, CCPE, FRCPC, Alison Fox-Robichaud, MSc, MD, FRCPC, on behalf of the Canadian Critical Care Translational Biology Group, Patricia Liaw, Jamie Hutchison, Jane Batt, Sean Gill, Jean-Francois Cailhier
Published 2021-04-01

The Effects of Biological Sex on Sepsis Treatments in Animal Models: A Systematic Review and a Narrative Elaboration on Sex- and Gender-Dependent Differences in Sepsis

by MengQi Zhang, BSc, Joshua Montroy, MSc, Rahul Sharma, HBSc, Dean A. Fergusson, MHA, PhD, Asher A. Mendelson, MD, PhD, FRCPC, Kimberly F. Macala, MD, FRCPC, Stephane L. Bourque, PhD, Jared M. Schlechte, BSc, Mikaela K. Eng, MSc, Braedon McDonald, MD, PhD, FRCPC, Sean E. Gill, PhD, Kirsten M. Fiest, PhD, Patricia C. Liaw, MSc, PhD, Alison Fox-Robichaud, MSc, MD, FRCPC, Manoj M. Lalu, MD, PhD, FRCPC, on behalf of the Canadian Critical Care Translational Biology Group and the Sepsis Canada National Preclinical Sepsis Platform
Published 2021-06-01